Skip to main content
Press Release

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

For Immediate Release
U.S. Attorney's Office, District of New Jersey

NEWARK, N.J. – A pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit prescriptions in exchange for cash, U.S. Attorney Philip R. Sellinger announced.

Anthony Duncan, 61, of Hillside, New Jersey, pleaded guilty before U.S. District Judge William J. Martini in Newark federal court to an information charging him with one count of conspiracy to distribute and possess with intent to distribute oxycodone and codeine.

According to documents filed in this case and statements made in court:

Duncan was a licensed pharmacist who owned and operated Parkway Central Pharmacy in East Orange, New Jersey. Duncan’s conspirators obtained bogus prescriptions for controlled substances, including oxycodone and codeine. They brought those bogus prescriptions to Duncan at Parkway Central, who filled the prescriptions knowing that they were false or counterfeit and that he was prohibited from dispensing controlled substances without a valid prescription.

Duncan accepted cash payments from his conspirators in exchange for filling the fraudulent and counterfeit prescriptions and dispensing controlled substances. He was generally paid $4 for every oxycodone 30mg pill; $2 for every oxycodone and acetaminophen combination product; and $10 for every eight ounces of cough syrup containing codeine. From November 2014 through November 2018, Duncan filled more than 1,100 false or counterfeit prescriptions for controlled substances. He illegally sold to one conspirator at least 47,000 tablets of Oxycodone 30 mg; 46,000 tablets of oxycodone and acetaminophen combination product; and 56,000 milliliters of cough syrup containing codeine.

The count of conspiracy to distribute and possess with intent to distribute oxycodone and codeine is punishable by a maximum penalty of 20 years in prison and a fine of up to $1 million, or twice the gross profit to the defendant, whichever is greater. Sentencing is scheduled for Nov. 8, 2022.

U.S. Attorney Sellinger credited special agents of the Drug Enforcement Administration, under the direction of Special Agent in Charge Susan A. Gibson, with the investigation leading to today’s guilty plea.

The government is represented by Assistant U.S. Attorney Hayden M. Brockett of the Health Care Fraud Unit in Newark.

Updated June 28, 2022

Prescription Drugs
Press Release Number: 22-239